Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Medecine Nucleaire ; 46(2):53, 2022.
Article in French | EMBASE | ID: covidwho-1983657

ABSTRACT

Déclaration de liens d’intérêts: Les auteurs déclarent ne pas avoir de liens d’intérêts.

2.
European Journal of Nuclear Medicine and Molecular Imaging ; 48(SUPPL 1):S146-S146, 2021.
Article in English | Web of Science | ID: covidwho-1610006
3.
Eur J Nucl Med Mol Imaging ; 48(9): 2823-2833, 2021 08.
Article in English | MEDLINE | ID: covidwho-1298551

ABSTRACT

PURPOSE: In the context of the worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some patients report functional complaints after apparent recovery from COVID-19. This clinical presentation has been referred as "long COVID." We here present a retrospective analysis of 18F-FDG brain PET of long COVID patients from the same center with a biologically confirmed diagnosis of SARS-CoV-2 infection and persistent functional complaints at least 3 weeks after the initial infection. METHODS: PET scans of 35 patients with long COVID were compared using whole-brain voxel-based analysis to a local database of 44 healthy subjects controlled for age and sex to characterize cerebral hypometabolism. The individual relevance of this metabolic profile was evaluated to classify patients and healthy subjects. Finally, the PET abnormalities were exploratory compared with the patients' characteristics and functional complaints. RESULTS: In comparison to healthy subjects, patients with long COVID exhibited bilateral hypometabolism in the bilateral rectal/orbital gyrus, including the olfactory gyrus; the right temporal lobe, including the amygdala and the hippocampus, extending to the right thalamus; the bilateral pons/medulla brainstem; the bilateral cerebellum (p-voxel < 0.001 uncorrected, p-cluster < 0.05 FWE-corrected). These metabolic clusters were highly discriminant to distinguish patients and healthy subjects (100% correct classification). These clusters of hypometabolism were significantly associated with more numerous functional complaints (brainstem and cerebellar clusters), and all associated with the occurrence of certain symptoms (hyposmia/anosmia, memory/cognitive impairment, pain and insomnia) (p < 0.05). In a more preliminary analysis, the metabolism of the frontal cluster which included the olfactory gyrus was worse in the 7 patients treated by ACE drugs for high blood pressure (p = 0.032), and better in the 3 patients that had used nasal decongestant spray at the infectious stage (p < 0.001). CONCLUSION: This study demonstrates a profile of brain PET hypometabolism in long COVID patients with biologically confirmed SARS-CoV-2 and persistent functional complaints more than 3 weeks after the initial infection symptoms, involving the olfactory gyrus and connected limbic/paralimbic regions, extended to the brainstem and the cerebellum. These hypometabolisms are associated with patients' symptoms, with a biomarker value to identify and potentially follow these patients. The hypometabolism of the frontal cluster, which included the olfactory gyrus, seems to be linked to ACE drugs in patients with high blood pressure, with also a better metabolism of this olfactory region in patients using nasal decongestant spray, suggesting a possible role of ACE receptors as an olfactory gateway for this neurotropism.


Subject(s)
COVID-19 , Fluorodeoxyglucose F18 , Brain/diagnostic imaging , COVID-19/complications , Humans , Positron-Emission Tomography , Retrospective Studies , SARS-CoV-2 , Post-Acute COVID-19 Syndrome
4.
Irish Medical Journal ; 113(10):1-11, 2020.
Article in English | Scopus | ID: covidwho-1013739

ABSTRACT

Aims The aim of this study was to provide an early interval evaluation of laboratory characteristics and clinical outcomes of adult patients with qRT-PCR-confirmed SARS-CoV-2 infection. Methods We performed a single-centre retrospective cohort study. All patients with qRT-PCR-confirmed SARS-CoV-2 infection admitted from March 6th to April 2nd were included. Daily laboratory, radiological and clinical parameters were manually collected on every patient. Results Forty-six patients were included in the analysis. Thirty-three (72%) of patients were male. The majority of patients (n=33, 89%) had at least one baseline comorbidity. Bilateral consolidation on chest x-ray (n=24, 52%) correlated with level of respiratory support required but not with mortality. Documented fever (n=33, 48%) and hypotension (n=4, 9%) correlated with highest level of respiratory support required. Older age, obesity and more than one baseline comorbid condition were associated with mortality. Regarding laboratory markers, degree of neutrophilia, lymphopenia (n=33, 73%) and raised CRP were significantly associated with death. Raised LDH, ferritin and D-dimer concentrations correlated with degree of oxygen requirement. There was no association between an early PCR cycle quantification (Cq) value (used as a proxy for viral load) and patient outcome. Conclusions We found multiple characteristics that correlated with outcome. These findings give an indication as to those patients that are at risk of a poor clinical outcome. © 2020, Irish Medical Association. All rights reserved.

SELECTION OF CITATIONS
SEARCH DETAIL